rs113926083

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_001365276.2(TNXB):​c.10893G>A​(p.Lys3631Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0492 in 148,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.049 ( 0 hom., cov: 25)
Exomes 𝑓: 0.068 ( 3 hom. )
Failed GnomAD Quality Control

Consequence

TNXB
NM_001365276.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.747

Publications

4 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 6-32045040-C-T is Benign according to our data. Variant chr6-32045040-C-T is described in ClinVar as Benign. ClinVar VariationId is 261099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.747 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.10893G>A p.Lys3631Lys synonymous_variant Exon 32 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.11634G>A p.Lys3878Lys synonymous_variant Exon 33 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.10887G>A p.Lys3629Lys synonymous_variant Exon 32 of 44 NP_061978.6
TNXBNM_032470.4 linkc.180G>A p.Lys60Lys synonymous_variant Exon 1 of 13 NP_115859.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.10893G>A p.Lys3631Lys synonymous_variant Exon 32 of 44 NM_001365276.2 ENSP00000496448.1

Frequencies

GnomAD3 genomes
AF:
0.0493
AC:
7308
AN:
148344
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0133
Gnomad AMI
AF:
0.103
Gnomad AMR
AF:
0.0442
Gnomad ASJ
AF:
0.121
Gnomad EAS
AF:
0.00468
Gnomad SAS
AF:
0.0227
Gnomad FIN
AF:
0.0336
Gnomad MID
AF:
0.0946
Gnomad NFE
AF:
0.0763
Gnomad OTH
AF:
0.0517
GnomAD2 exomes
AF:
0.0526
AC:
12016
AN:
228440
AF XY:
0.0539
show subpopulations
Gnomad AFR exome
AF:
0.0115
Gnomad AMR exome
AF:
0.0316
Gnomad ASJ exome
AF:
0.124
Gnomad EAS exome
AF:
0.00660
Gnomad FIN exome
AF:
0.0369
Gnomad NFE exome
AF:
0.0770
Gnomad OTH exome
AF:
0.0650
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0683
AC:
95093
AN:
1391566
Hom.:
3
Cov.:
33
AF XY:
0.0681
AC XY:
47162
AN XY:
693038
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0104
AC:
346
AN:
33174
American (AMR)
AF:
0.0334
AC:
1449
AN:
43404
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
3095
AN:
24500
East Asian (EAS)
AF:
0.00997
AC:
372
AN:
37320
South Asian (SAS)
AF:
0.0263
AC:
2214
AN:
84132
European-Finnish (FIN)
AF:
0.0388
AC:
1977
AN:
50996
Middle Eastern (MID)
AF:
0.0890
AC:
485
AN:
5450
European-Non Finnish (NFE)
AF:
0.0770
AC:
81213
AN:
1054722
Other (OTH)
AF:
0.0681
AC:
3942
AN:
57868
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.287
Heterozygous variant carriers
0
8189
16378
24567
32756
40945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2912
5824
8736
11648
14560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0492
AC:
7307
AN:
148460
Hom.:
0
Cov.:
25
AF XY:
0.0470
AC XY:
3412
AN XY:
72642
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0133
AC:
548
AN:
41268
American (AMR)
AF:
0.0442
AC:
656
AN:
14854
Ashkenazi Jewish (ASJ)
AF:
0.121
AC:
393
AN:
3236
East Asian (EAS)
AF:
0.00469
AC:
24
AN:
5112
South Asian (SAS)
AF:
0.0231
AC:
110
AN:
4752
European-Finnish (FIN)
AF:
0.0336
AC:
349
AN:
10384
Middle Eastern (MID)
AF:
0.0912
AC:
25
AN:
274
European-Non Finnish (NFE)
AF:
0.0763
AC:
5008
AN:
65664
Other (OTH)
AF:
0.0511
AC:
105
AN:
2054
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.307
Heterozygous variant carriers
0
474
947
1421
1894
2368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0830
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
6.4
DANN
Benign
0.87
PhyloP100
-0.75
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113926083; hg19: chr6-32012817; COSMIC: COSV64472793; COSMIC: COSV64472793; API